10 Participants Needed

Indoor Air Quality Monitor for Smoking Cessation

Recruiting at 7 trial locations
MB
JO
Overseen ByJamie Ostroff, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.

Do I need to stop taking my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It focuses on using an air quality monitor to help quit smoking, so it's best to ask the trial coordinators for more details.

What data supports the effectiveness of the treatment Indoor Air Quality Monitor AirGradient ONE for smoking cessation?

Research shows that using air quality monitors and air cleaners can help reduce indoor air pollution, which has been linked to better respiratory health. In a study, air cleaners improved symptoms in people with chronic obstructive pulmonary disease (COPD), suggesting that improving indoor air quality might also support smoking cessation efforts by highlighting the impact of smoking on air quality.12345

Is the Indoor Air Quality Monitor for Smoking Cessation safe for humans?

The research articles do not provide specific safety data for the Indoor Air Quality Monitor for Smoking Cessation or its related models. However, they discuss the use of air quality monitors in general, which are used to measure indoor air pollution from smoking, and there are no reported safety concerns related to the monitors themselves.36789

How does the Indoor Air Quality Monitor for Smoking Cessation differ from other treatments for smoking cessation?

The Indoor Air Quality Monitor for Smoking Cessation is unique because it uses a device to measure carbon monoxide levels in the air, helping individuals track their smoking habits in real-time. Unlike traditional methods that rely on self-reporting or standalone devices, this approach provides continuous, objective feedback, potentially increasing awareness and motivation to quit smoking.1011121314

Research Team

Jamie S. Ostroff, PhD - MSK Psychologist

Jamie Ostroff, PhD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Eligibility Criteria

This trial is for cancer patients trying to quit smoking and are enrolled in MSK's Tobacco Treatment Program. It aims to see if using an air quality monitor helps them keep their homes smoke-free.

Inclusion Criteria

Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
I am over 18 years old.
See 4 more

Exclusion Criteria

N/A

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use an indoor air quality monitor and attend smoke-free workshop sessions

8 weeks
Participants use the device for 14 consecutive days and attend workshops

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Indoor Air Quality Monitor AirGradient ONE
Trial OverviewThe study is testing the effectiveness of the AirGradient ONE indoor air quality monitor in encouraging a smoke-free environment at home among participants.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: MSK Participants who are current smokersExperimental Treatment1 Intervention
10 MSK participants who are current smokers and receiving tobacco treatment will be enrolled.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials
1,998
Recruited
602,000+

Findings from Research

The use of active portable high-efficiency particulate air cleaners showed a significant reduction in respiratory symptoms and moderate exacerbations in former smokers with COPD over a 6-month period, indicating potential health benefits from reducing indoor particulate matter.
Participants who adhered to using the air cleaners and spent more time indoors experienced greater improvements in their respiratory health, suggesting that these devices could be particularly effective for individuals with COPD in indoor environments.
Randomized Clinical Trial of Air Cleaners to Improve Indoor Air Quality and Chronic Obstructive Pulmonary Disease Health: Results of the CLEAN AIR Study.Hansel, NN., Putcha, N., Woo, H., et al.[2023]
In a 6-month study involving 116 former smokers with COPD, 76.1% of participants adhered to using portable air cleaners at least 80% of the time, which could potentially improve their respiratory health by reducing indoor pollutants.
Factors such as higher household income and using electric heating were linked to better adherence, while lower quality of life and recent exacerbations were associated with lower adherence, indicating that socioeconomic and health status play crucial roles in the effectiveness of air cleaner interventions.
Patterns and Predictors of Air Cleaner Adherence Among Adults with COPD.Lorizio, W., Woo, H., McCormack, MC., et al.[2022]
The study involved 39 pregnant women who smoke, and qualitative interviews revealed that while many wanted to change their smoking behaviors, external factors like living with other smokers often hindered their commitment to quitting.
Although indoor air quality (IAQ) measurements did not significantly improve overall quit rates, they did help some women modify their smoking behaviors, suggesting that this approach could be beneficial in supporting smoking cessation efforts during pregnancy.
An interview study of pregnant women who were provided with indoor air quality measurements of second hand smoke to help them quit smoking.Morgan, H., Treasure, E., Tabib, M., et al.[2021]

References

Randomized Clinical Trial of Air Cleaners to Improve Indoor Air Quality and Chronic Obstructive Pulmonary Disease Health: Results of the CLEAN AIR Study. [2023]
Patterns and Predictors of Air Cleaner Adherence Among Adults with COPD. [2022]
An interview study of pregnant women who were provided with indoor air quality measurements of second hand smoke to help them quit smoking. [2021]
A randomized trial of air cleaners and a health coach to improve indoor air quality for inner-city children with asthma and secondhand smoke exposure. [2021]
Cardiorespiratory responses of air filtration: A randomized crossover intervention trial in seniors living in Beijing: Beijing Indoor Air Purifier StudY, BIAPSY. [2019]
Indoor air quality (IAQ) evaluation of a Novel Tobacco Vapor (NTV) product. [2023]
Feasibility of Measuring Tobacco Smoke Air Pollution in Homes: Report from a Pilot Study. [2018]
Monitoring secondhand tobacco smoke remotely in real-time: A simple low-cost approach. [2023]
Preliminary study on the effect of using heat-not-burn tobacco products on indoor air quality. [2022]
A mobile-phone-based breath carbon monoxide meter to detect cigarette smoking. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
A wearable sensor system for monitoring cigarette smoking. [2021]
Mobile, Remote, and Individual Focused: Comparing Breath Carbon Monoxide Readings and Abstinence Between Smartphone-Enabled and Stand-Alone Monitors. [2021]
ANALYSIS OF AGREEMENT BETWEEN EXPIRED-AIR CARBON MONOXIDE MONITORS. [2022]
14.United Statespubmed.ncbi.nlm.nih.gov
Evaluation of a portable measure of expired-air carbon monoxide. [2019]